1cP-LSD

From WikiMD's Wellness Encyclopedia

A psychedelic compound related to LSD


CaptionSynonyms
1cP-LSD
Drug Information
Image
Identifiers

CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL

Chemical Data

C H N O Molecular Weight



1cP-LSD (1-cyclopropionyl-d-lysergic acid diethylamide) is a psychedelic compound that is structurally related to LSD (lysergic acid diethylamide). It is part of a class of substances known as lysergamides, which are known for their potent effects on the human mind, often inducing altered states of consciousness, visual hallucinations, and changes in perception.

Chemical Structure and Properties[edit | edit source]

1cP-LSD is a derivative of LSD, with a cyclopropionyl group attached to the nitrogen of the indole ring. This modification is believed to affect the compound's pharmacokinetics, potentially altering its onset, duration, and intensity of effects compared to LSD. The chemical formula of 1cP-LSD is C23H29N3O2, and it has a molecular weight of 379.50 g/mol.

Pharmacology[edit | edit source]

1cP-LSD is thought to act primarily as a partial agonist at the 5-HT2A receptor, similar to other psychedelics. This interaction is believed to be responsible for its psychoactive effects. The compound may also interact with other serotonin receptors, contributing to its overall pharmacological profile.

Effects[edit | edit source]

The effects of 1cP-LSD are reported to be similar to those of LSD, including:

  • Visual and auditory hallucinations
  • Altered perception of time and space
  • Enhanced introspection and emotional experiences
  • Synesthesia (e.g., "seeing" sounds or "hearing" colors)
  • Euphoria and a sense of well-being

The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the peak effects lasting 6 to 10 hours, followed by a gradual comedown.

Legal Status[edit | edit source]

The legal status of 1cP-LSD varies by country. In some jurisdictions, it is considered a controlled substance, while in others, it may be legal or exist in a legal gray area. Users should be aware of the laws in their region before obtaining or using 1cP-LSD.

Safety and Risks[edit | edit source]

As with other psychedelics, the use of 1cP-LSD carries potential risks, including:

  • Psychological distress or "bad trips"
  • Anxiety and paranoia
  • Potential for triggering latent mental health disorders
  • Physical risks associated with impaired judgment and perception

Users are advised to approach the use of 1cP-LSD with caution, ensuring a safe and supportive environment and considering the potential psychological effects.

Also see[edit | edit source]




WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD